Palforzia

Status:

Red

Decision Date:

March 2022

Comments

RED: NICE TA769 - Palforzia for treating peanut allergy in children and young people. (Decision date - March 2022)

Red Drug Classifications

• 1: Requiring specialist assessment to enable patient selection, initiation and ongoing treating

search again